EPOR Clause Samples

EPOR. Viking shall pay Ligand the following one-time, non-refundable milestone payments with respect to Licensed Products containing an EPOR Compound as follows: The end of the […***…] during which cumulative Net Sales for all Licensed Products containing an EPOR Compound reach or surpass […***…] […***…] The end of the […***…] during which cumulative Net Sales for all Licensed Products containing an EPOR Compound reach or surpass […***…] […***…] The end of the […***…] during which cumulative Net Sales for all Licensed Products containing an EPOR Compound reach or surpass […***…] […***…]
EPOR. Viking shall, during the applicable Royalty Term, pay to Ligand a royalty on aggregate annual worldwide Net Sales by Viking and its Affiliates and Sublicensees of all Licensed Products with one or more Valid Claims Covering any EPOR Compound contained in such Licensed Products, at the percentage rates set forth below: For Net Sales of such a Licensed Product from […***…] up to and including […***…] […***…]% For that portion of Net Sales of a Licensed Product that is greater than […***…] and less than or equal to […***…] […***…]% For that portion of Net Sales of a Licensed Product that is greater than […***…] […***…]% By way of illustration, assume in a Calendar Year that aggregate worldwide annual Net Sales of all such Licensed Products total $950,000,000. The total royalties due and payable by Viking to Ligand for such Net Sales would be […***…], calculated as follows: […***…]
EPOR. Viking shall, during the applicable Royalty Term, pay to Ligand a royalty on aggregate annual worldwide Net Sales by Viking and its Affiliates and Sublicensees of all Licensed Products with one or more Valid Claims Covering any EPOR Compound contained in such Licensed Products, at the percentage rates set forth below: ***Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. For Net Sales of such a Licensed Product from [***] up to and including [***] [***] For that portion of Net Sales of a Licensed Product that is greater than [***] and less than or equal to [***] [***] For that portion of Net Sales of a Licensed Product that is greater than [***] [***] By way of illustration, assume in a Calendar Year that aggregate worldwide annual Net Sales of all such Licensed Products total $950,000,000. The total royalties due and payable by Viking to Ligand for such Net Sales would be [***], calculated as follows: [***]
EPOR. Viking shall, during the applicable Royalty Term, pay to Ligand a royalty on aggregate annual worldwide Net Sales by Viking and its Affiliates and Sublicensees of all Licensed Products with one or more Valid Claims Covering any EPOR Compound contained in such Licensed Products, at the percentage rates set forth below: For Net Sales of such a Licensed Product from [***] up to and including [***] [***]% For that portion of Net Sales of a Licensed Product that is greater than [***] and less than or equal to [***] [***]% For that portion of Net Sales of a Licensed Product that is greater than [***] [***]% By way of illustration, assume in a Calendar Year that aggregate worldwide annual Net Sales of all such Licensed Products total $950,000,000. The total royalties due and payable by Viking to Ligand for such Net Sales would be [***], calculated as follows: [***]